Former New Jersey Health Commissioner Dr. Poonam Alaigh Named Perminova Advisor

Share Article

Perminova, developer of web-based software for the nation’s leading cardiology centers, announced that Poonam Alaigh, MD, has joined the Perminova Board of Advisors. A board-certified internist with a vascular medicine specialty, Dr. Alaigh was Commissioner of Health and Senior Services for the State of New Jersey.

Dr. Poonam Alaigh was named to the Perminova Board of Advisors. She was Commissioner of Health and Senior Services for the State of New Jersey, an executive-level state agency with a $3.8 billion budget.

Perminova is fortunate to have on its Board of Advisors an MD with Dr. Alaigh’s tremendous expertise in healthcare policy. In this fast-changing era for healthcare, her knowledge will be extremely beneficial to our high-growth health technology.

Perminova, developer of web-based software for the nation’s leading cardiology centers, announced that Poonam Alaigh, MD, has joined the Perminova Board of Advisors.

A board-certified internist with a vascular medicine specialty, Dr. Alaigh also has a comprehensive knowledge of health policy, healthcare reform, cost-effective care and quality outcomes, along with expertise in organizational and corporate management. She was Commissioner of Health and Senior Services for the State of New Jersey, where she led an executive-level state agency with a $3.8 billion budget and 1,700 employees and answered directly to the Governor. Her key responsibilities included state and national healthcare policy, public health, senior care and quality and regulatory oversight of healthcare institutions in New Jersey.

“Perminova is fortunate to have on its Board of Advisors an MD with Dr. Alaigh’s tremendous expertise in healthcare policy, along with organizational and corporate management,” said Craig K. Collins, Perminova President and CEO. “In this fast-changing era for healthcare, her knowledge will be extremely beneficial to our high-growth health technology company.”

Previously, she was Executive Medical Director of Horizon Blue Cross Blue Shield of New Jersey, National Medical Director of GlaxoSmithKline Pharmaceuticals, Medical Director of Vytra Health Plans of New York, and Associate Medical Director of the Long Island Medical Care Group.

Her clinical practice was at the Veterans Administration Hospital in Lyons, NJ. Dr. Alaigh also is an Assistant Professor in the Department of Family Practice at UMDNJ-Robert Wood Johnson Medical School. She has been very active in the American Heart Association, including as a Board Member of the Founders Affiliate, President of the Board for New Jersey and Board Member for the Tristate Region.

Dr. Alaigh received her medical degree from Lady Hardinge Medical College at Delhi University in India and later an MS in Health Care Policy and Management at SUNY at Stony Brook in New York.

About Perminova

La Jolla, Calif.-based Perminova develops and markets web-based software for use in cardiovascular surgery. The company is pioneering healthcare’s move from outdated client-server technology to modern, secure cloud computing. Perminova offers customers Software-as-a-Service (SaaS), allowing them to take full advantage of a surgical information system that’s more robust, flexible and cost-effective than currently available. In 2011, the company released Perminova EP, a software module that manages the scheduling, workflow and billing that occur before, during and after cardiac electrophysiological (EP) procedures. Perminova EP enables doctors, nurses and administrators to realize enhanced charge-capture, efficiency and patient safety. The software is currently deployed at leading cardiology centers throughout the United States, including UC San Diego Health System and Mount Sinai Hospital in New York.

###

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Eileen Lane

Jim Gogek
Perminova
866-584-5884 109
Email >
Visit website